Vaccines

Pfizer, BioNTech to Develop mRNA-based Flu Vaccines

August 16, 2018

Pharmaceutical Technology's In the Lab eNewsletter

The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.

Ebola Vaccinations Begin in Response to Congo’s Last Outbreak

August 09, 2018

Ebola vaccinations by the World Health Organization began in North Kivu, Democratic Republic of the Congo, one week after the country’s latest outbreak.

Sanofi Pasteur, Translate Bio in $805-Million Deal to Develop mRNA-Based Vaccines

June 22, 2018

The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.

Research Shows Promise for Syphilis Vaccine

June 14, 2018

Microbiologists from the University of Connecticut have pinpointed exterior proteins on syphilis-causing bacteria that could serve as vaccine targets for syphilis.

WHO Vaccinates Against Ebola with Merck & Co.'s Experimental Vaccine

May 30, 2018

World Health Organization’s Ebola ring vaccination uses Merck & Co.’s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

May 09, 2018

The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.

Pandemic Fears Stoke Calls for New Vaccines and Global Health Initiatives

May 02, 2018

Public health authorities and the biomedical research community are seeking new strategies to address global health threats.

EMA Updates Flu Vaccine Recommendations

April 30, 2018

The agency updated its list of recommended influenza virus strains that manufacturers should include in vaccines for the autumn 2018 season.

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

April 12, 2018

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.

Modern Manufacturing Key to More Effective Vaccines

April 02, 2018

Accelerated development of new preventives raises challenges for efficient CMC evaluation and production.